Martine Rothblatt talks on CNBC about United Therapeutics Corp.'s future in organ manufacturing - Washington Business Journal

Martine Rothblatt has made no secret of her goal to move beyond the pharmaceutical business model that made her first foray into the biotech world — United Therapeutics Corp. (NASDAQ: UTHR) — a striking success.